HCW Biologics Enters CRADA with National Cancer Institute

Author's Avatar
Dec 08, 2022

NCI Activated as Clinical Site for Phase 1b/2 Clinical Trial to Evaluate HCW9218 in Advanced Pancreatic Cancer